Relevant bibliographies by topics / Anticancer drugs

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Anticancer drugs'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Anticancer drugs.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Anticancer drugs"

1

D, Subba Reddy, Prasanthi G, Amruth Raj S, Hari Krishna T, Sowjanya K, and Shantha Kumari K. "EVALUATION OF ANTICANCER GENERIC DRUGS AND BRANDED DRUGS." Indian Research Journal of Pharmacy and Science 5, no. 1 (2018): 1378–91. http://dx.doi.org/10.21276/irjps.2018.5.1.16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Reese, David M. "Anticancer drugs." Nature 378, no. 6557 (1995): 532. http://dx.doi.org/10.1038/378532c0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jorayev, Muhammadyusuf Abdurakhim ugli Juraev Mukhammadyusuf. "ANTICANCER DRUGS." INTERNATIONAL BULLETIN OF MEDICAL SCIENCES AND CLINICAL RESEARCH 3, no. 4 (2023): 114–17. https://doi.org/10.5281/zenodo.7854262.

Full text
Abstract:
The article presents an overview of anticancer drugs for medical use currently registered in Uzbekistan and at the final stage of their development - clinical trials in accredited testing centers for subsequent registration. The generalized information was obtained from official sources - the State Register of Medicines of the Ministry of Health of Uzbekistan, the Electronic Rubricator of Clinical Recommendations and Clinical Guidelines and orders on the Standards of Medical Care prepared on their basis. The place and role of chemotherapeutic agents in the treatment of oncological patients and
APA, Harvard, Vancouver, ISO, and other styles
4

Kutty, Dr A. V. M. "Usefulness of Phytochemicals as Anticancer Drugs." JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 16, no. 1 (2019): 1–2. http://dx.doi.org/10.58739/jcbs/v09i1.7.

Full text
Abstract:
Cancer is a state of uncontrolled proliferation and dedifferentiation of cells in any tissues or organs of the body. The incidence of cancer is rising alarmingly and is one of the leading causes of morbidity and mortality globally. Normal cell division is precisely a planned biological process controlled by regulatory genes and specific metabolic pathways. Exposure of normally functioning cells to carcinogens leads to mutations in the genes causing loss of control of cell division and transform into cancerous. Over a period of time, these cancer cells acquire more mutations; invade to adjoinin
APA, Harvard, Vancouver, ISO, and other styles
5

Atkins, Joshua H., and Leland J. Gershell. "Selective anticancer drugs." Nature Reviews Drug Discovery 1, no. 7 (2002): 491–92. http://dx.doi.org/10.1038/nrd842.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Atkins, Joshua H., and Leland J. Gershell. "Selective anticancer drugs." Nature Reviews Cancer 2, no. 9 (2002): 645–46. http://dx.doi.org/10.1038/nrc900.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bibby, M. C. "Combretastatin anticancer drugs." Drugs of the Future 27, no. 5 (2002): 475. http://dx.doi.org/10.1358/dof.2002.027.05.668645.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Meegan, Mary J., and Niamh M. O’Boyle. "Special Issue “Anticancer Drugs”." Pharmaceuticals 12, no. 3 (2019): 134. http://dx.doi.org/10.3390/ph12030134.

Full text
Abstract:
The focus of this Special Issue of Pharmaceuticals is on the design, synthesis, and molecular mechanism of action of novel antitumor, drugs with a special emphasis on the relationship between the chemical structure and the biological activity of the molecules. This Special Issue also provides an understanding of the biologic and genotypic context in which targets are selected for oncology drug discovery, thus providing a rationalization for the biological activity of these drugs and guiding the design of more effective agents. In this Special Issue of Pharmaceuticals dedicated to anticancer dr
APA, Harvard, Vancouver, ISO, and other styles
9

Ciarimboli, Giuliano. "Anticancer Platinum Drugs Update." Biomolecules 11, no. 11 (2021): 1637. http://dx.doi.org/10.3390/biom11111637.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Zhang, Jason Y. "Apoptosis-based anticancer drugs." Nature Reviews Drug Discovery 1, no. 2 (2002): 101–2. http://dx.doi.org/10.1038/nrd742.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Anticancer drugs"

1

Apps, MIchael Garry. "Platinum anticancer drugs and drug delivery systems." Thesis, The University of Sydney, 2015. http://hdl.handle.net/2123/14409.

Full text
Abstract:
In this thesis two different ways to improve platinum-based chemotherapy were investigated. The first was through the use of a new slow release clay-based drug delivery vehicle and the second through the design and synthesis of novel dinuclear platinum complexes. For the clay-based drug delivery research, the platinum anticancer complex [(1,10-phenanthroline)(1S,2S-diaminocyclohexane)platinum(II)] chloride, PHENSS, was loaded into montmorillonite (MMT) clay. The PHENSS was found to be incompletely burst released from the MMT. The MMT also had a negative effect on the in vitro cytotoxicity of P
APA, Harvard, Vancouver, ISO, and other styles
2

Kozlowska, Hanna. "Interaction of dexrazoxane with anticancer drugs." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape17/PQDD_0001/MQ32158.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tao, Zhimin. "Analysis of cytotoxicity of anticancer drugs." Related electronic resource:, 2007. http://proquest.umi.com/pqdweb?did=1407688361&sid=4&Fmt=2&clientId=3739&RQT=309&VName=PQD.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Liu, Tong. "The synthesis of novel anticancer drugs." Thesis, University of Glasgow, 2003. http://theses.gla.ac.uk/4464/.

Full text
Abstract:
Our studies on the synthesis and biological evaluation of novel anticancer drugs consist of three research areas; namely, synthesis of Mitogen Activated Protein (MAP) kinase inhibitors, Checkpoint (Chk1) inhibitors and nordihydroguaiaretic acid (NDGA) analogues. The first research area involved synthesis of MAP kinase inhibitors. MAP kinases are a family of serine I and threonine II kinases which can act together to generate a process of phosphorylation events within the cell signalling pathway leading eventually to cell division. The compounds made in this project were specifically designed t
APA, Harvard, Vancouver, ISO, and other styles
5

Song, Di. "Bladder tissue pharmacokinetics of anticancer drugs /." The Ohio State University, 1996. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487940308433249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ratcliffe, Andrew J. "Synthesis of non-mutagenic anticancer drugs." Thesis, University of Bath, 1987. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378598.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pettersson, Hanna Ilse. "Quinolinequinones as anticancer agents." Thesis, University of Exeter, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.249038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wang, Shining. "DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS." Diss., Temple University Libraries, 2008. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/2535.

Full text
Abstract:
Pharmaceutics<br>Ph.D.<br>EGFR inhibitors, such as gefitinib, are examples of targeted anticancer drugs whose drug sensitivity is related to gene mutations that adds a pharmacogenetic [PG] dimension to any pharmacokinetic [PK] and pharmacodynamic [PD] analysis. The goal of this project was to characterize the PK/PD properties of gefitinib in tumors and then apply these results to design rational drug design regimens, and provide a foundation for future studies with EGFR inhibitors. Progressions of in vitro and in vivo studies were completed to understand the PK and PD behavior of gefitinib. In
APA, Harvard, Vancouver, ISO, and other styles
9

Leczkowska, Anna. "Non-covalent DNA-binding ruthenium anticancer drugs." Thesis, University of Birmingham, 2011. http://etheses.bham.ac.uk//id/eprint/1695/.

Full text
Abstract:
The research work described in this thesis concerns metal-based anticancer drugs with an emphasis on non-covalent DNA-binding supramolecular assemblies. The project involves the preparation of a series of mono- and bi-metallic ruthenium complexes with a primary focus on fluorescent dinuclear triple-stranded helicates with different structural topographies. Emphasis is then directed towards an investigation of the DNA binding characteristics of these molecules and an evaluation of their anticancer properties in human cancer cell lines. Attention is brought to the significance that the cylinder-
APA, Harvard, Vancouver, ISO, and other styles
10

Yarema, Kevin J. (Kevin Jon). "Cellular responses to platinum-based anticancer drugs." Thesis, Massachusetts Institute of Technology, 1994. http://hdl.handle.net/1721.1/33495.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Anticancer drugs"

1

1938-, Pratt William B., and Pratt William B. 1938-, eds. The anticancer drugs. 2nd ed. Oxford University Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Garth, Powis, ed. Anticancer drugs: Reactive metabolism and drug interactions. Pergamon Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Avendaño, Carmen. Medicinal chemistry of anticancer drugs. Elsevier, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Convention, United States Pharmacopeial. Fact sheets on anticancer drugs. National Cancer Institute [distributor], 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Garth, Powis, and Hacker Miles P, eds. The Toxicity of anticancer drugs. Pergamon Press, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

National Cancer Institute (U.S.), ed. Fact sheets on anticancer drugs. National Cancer Institute, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

1964-, Spencer Peter, and Holt Walter, eds. Anticancer drugs: Design, delivery and pharmacology. Nova Science Publishers, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Saeidnia, Soodabeh. New Approaches to Natural Anticancer Drugs. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-14027-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hacker, Miles P., John S. Lazo, and Thomas R. Tritton, eds. Organ Directed Toxicities of Anticancer Drugs. Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-2023-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hildebrand, Jerzy, ed. Neurological Adverse Reactions to Anticancer Drugs. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-76142-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Anticancer drugs"

1

Schacter, Lee, Marcel Rozencweig, Claude Nicaise, Renzo Canetta, Susan Kelley, and Laurie Smaldone. "Anticancer Drugs." In Early Phase Drug Evaluation in Man. Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-10705-6_49.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Schwab, Matthias, Elke Schaeffeler, and Hiltrud Brauch. "Anticancer Drugs." In Metabolism of Drugs and Other Xenobiotics. Wiley-VCH Verlag GmbH & Co. KGaA, 2012. http://dx.doi.org/10.1002/9783527630905.ch13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Isnard-Bagnis, Corinne, Vincent Launay-Vacher, Svetlana Karie, and Gilbert Deray. "Anticancer drugs." In Clinical Nephrotoxins. Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-84843-3_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zhao, Le, Zengyi Shao, and Jacqueline V. Shanks. "Anticancer Drugs." In Industrial Biotechnology. Wiley-VCH Verlag GmbH & Co. KGaA, 2016. http://dx.doi.org/10.1002/9783527807833.ch8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ganguly, A. K., and Sesha Sridevi Alluri. "Anticancer Drugs." In Medicinal Chemistry. CRC Press, 2021. http://dx.doi.org/10.1201/9781003182573-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Isnard-Bagnis, Corinne, and Gilbert Deray. "Anticancer drugs." In Clinical Nephrotoxins. Springer Netherlands, 2003. http://dx.doi.org/10.1007/1-4020-2586-6_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cateni, Francesca, and Marina Zacchigna. "PEG–Anticancer Drugs." In Macromolecular Anticancer Therapeutics. Springer New York, 2009. http://dx.doi.org/10.1007/978-1-4419-0507-9_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kim, Kyu-Won, Jae Kyung Roh, Hee-Jun Wee, and Chan Kim. "Immunotherapeutic Anticancer Drugs and Other Miscellaneous Anticancer Drugs." In Cancer Drug Discovery. Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-024-0844-7_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kim, Kyu-Won, Jae Kyung Roh, Hee-Jun Wee, and Chan Kim. "Alkylating Anticancer Drugs." In Cancer Drug Discovery. Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-024-0844-7_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kim, Kyu-Won, Jae Kyung Roh, Hee-Jun Wee, and Chan Kim. "Antimetabolic Anticancer Drugs." In Cancer Drug Discovery. Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-024-0844-7_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Anticancer drugs"

1

Shiranirad, Saba, and Zeynab Barzegar. "Predictive Modeling of Drug Release from Liposomal Nano-Anticancer Drugs Using Advanced Machine Learning Techniques and TreeSHAP for Interpretability." In 2025 Eighth International Women in Data Science Conference at Prince Sultan University (WiDS PSU). IEEE, 2025. https://doi.org/10.1109/wids-psu64963.2025.00052.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ma, Liang, Jeremy Barker, Changchun Zhou, Biaoyang Lin, and Wei Li. "A Perfused Two-Chamber System for Anticancer Drug Screening." In ASME 2010 International Manufacturing Science and Engineering Conference. ASMEDC, 2010. http://dx.doi.org/10.1115/msec2010-34326.

Full text
Abstract:
A cell culture microfluidic device has been developed to test the cytotoxicity of anticancer drugs while reproducing multi-organ interactions in vitro. Cells were cultured in separate chambers representing the liver and tumor. The two chambers were connected through a channel to mimick the blood flow. Glioblastoma (GBM) cancer cells (M059K) and hepatoma cells (HepG2) were cultured in the tumor and the liver chambers, respectively. The cytotoxic effect of cancer treatment drug Temolozomide (TMZ) was tested using this two chamber system. The experimental results showed that with the liver cells,
APA, Harvard, Vancouver, ISO, and other styles
3

Schiestl, Robert H., Michael Davoren, and Yelena Rivina. "Abstract 1793: Novel radiation mitigators and anticancer drugs." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-1793.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Settleman, Jeffrey E. "Abstract CN06-04: Reversible tolerance to anticancer drugs." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-cn06-04.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Schiestl, Robert H., Yelena Rivina, and Michael Davoren. "Abstract 3729: Novel radiation mitigators and anticancer drugs." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-3729.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zhukovets, T. A., M. А. Khancheuski, I. V. Koktysh, E. I. Kvasyuk, and A. G. Sysa. "ANTIOXIDANT EFFECTS OF EMOXYPINE AS ADJUVANT OF ANTI-CANCER DRUGS." In SAKHAROV READINGS 2021: ENVIRONMENTAL PROBLEMS OF THE XXI CENTURY. International Sakharov Environmental Institute of Belarusian State University, 2021. http://dx.doi.org/10.46646/sakh-2021-2-52-55.

Full text
Abstract:
Antioxidants are known to minimize oxidative stress by interacting with free radicals produced as a result of cell aerobic reactions. Oxidative stress has long been linked to many diseases, especially tumours. Therefore, antioxidants play a crucial role in the prevention or management of free radical-related diseases. However, most of these antioxidants have anticancer effects only if taken in large doses. Therefore, the combined use of antioxidants with chemotherapeutic agents is an attractive strategy to combat various tumours. This article focuses on the antioxidant effect of emoxypine. The
APA, Harvard, Vancouver, ISO, and other styles
7

Cao, Tingying, Xiangdong Gao, and Yueqing Gu. "Biodegradable polylactide microspheres containing anticancer drugs used as injectable drug delivery system." In 2007 IEEE/ICME International Conference on Complex Medical Engineering. IEEE, 2007. http://dx.doi.org/10.1109/iccme.2007.4381726.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

J., Alex Mathew, and Nixon Raj N. "Insilico Docking Studies on Anticancer Drugs for Breast Cancer." In 2009 International Association of Computer Science and Information Technology - Spring Conference. IEEE, 2009. http://dx.doi.org/10.1109/iacsit-sc.2009.12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Shrestha, Gajendra, Michael Xiao, Richard Robison, Larry L. St Clair, and Kim O'Neill. "Abstract 3220: Lichen derived polyphenols as potential anticancer drugs." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3220.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ribeiro, Tatiane. "23 Evidence-based medicine challenges in new anticancer drugs." In EBM Live Abstracts, July 2019, Oxford, UK. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/bmjebm-2019-ebmlive.104.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Anticancer drugs"

1

Howard, David, Peter Bach, Ernst Berndt, and Rena Conti. Pricing in the Market for Anticancer Drugs. National Bureau of Economic Research, 2015. http://dx.doi.org/10.3386/w20867.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zhang, Jian-Ting. Molecular Study of Interactions between P-Glycoprotein and Anticancer Drugs. Defense Technical Information Center, 1995. http://dx.doi.org/10.21236/ada300162.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Inoue, Takashi, and Mamoru Narukawa. Anti-tumor efficacy of anti-PD-1/PD-L1 antibodies in combination with other anticancer drugs in solid tumors: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.10.0004.

Full text
Abstract:
Review question / Objective: The aim of this systematic review is to compare the combination of PD-1/PD-L1 inhibitors plus other anticancer drugs and monotherapies of PD-1/PD-L1 inhibitors in terms of antitumor efficacy in the solid tumors to better inform clinical practice. To this end, the proposed systematic review will address the following question: Which is the best choice to enhance response rate in subjects with solid tumors, PD-1/PD-L1 inhibitors plus cytotoxic agents or PD-1/PD-L1 inhibitors plus other targeted anticancer drugs? Condition being studied: Cancer is the leading cause of
APA, Harvard, Vancouver, ISO, and other styles
4

Biswas, Kaustav, and Samuel J. Danishefsky. Synthesis of Epothilone Analogs: Toward the Development of Potent Anticancer Drugs. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada409475.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Feltmate, Colleen. Application of Nanotechnology in the Targeted Release of Anticancer Drugs in Ovarian Cancer Treatment. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada486569.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Feltmate, Colleen. Application of Nanotechnology in the Targeted Release of Anticancer Drugs in Ovarian Cancer Treatment. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada481424.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Beerman, Terry A. Discovery of DNA Binding Anticancer Drugs That Target Oncogenic Transcription Factors Associated With Human Breast Cancer. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada403322.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Venedicto, Melissa, and Cheng-Yu Lai. Facilitated Release of Doxorubicin from Biodegradable Mesoporous Silica Nanoparticles. Florida International University, 2021. http://dx.doi.org/10.25148/mmeurs.009774.

Full text
Abstract:
Cervical cancer is one of the most common causes of cancer death for women in the United States. The current treatment with chemotherapy drugs has significant side effects and may cause harm to healthy cells rather than cancer cells. In order to combat the potential side effects, nanoparticles composed of mesoporous silica were created to house the chemotherapy drug doxorubicin (DOX). The silica network contains the drug, and a pH study was conducted to determine the conditions for the nanoparticle to disperse the drug. The introduction of disulfide bonds within the nanoparticle created a fram
APA, Harvard, Vancouver, ISO, and other styles
9

Macedo, Luciana, and Linda Malkas. The Human Breast Cancer DNA Synthesome Can Serve as a Novel In Vitro Model System for Studying the Mechanism of Action of Anticancer Drugs. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada393926.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jiang, Haiyan. The Human Breast Cancer Cell DNA Synthesome Can Serve as a Novel in Vitro Model System for Studying the Mechanism of Action of Anticancer Drugs. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada384124.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Anticancer drugs' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography